Summary
The kinetics of accumulation and elimination of d- and l-fenfluramine (F) and norfenfluramine (NF) have been studied in 8 young healthy volunteers given daily doses of 60 mg of sugar-coated tablets of 20 mg dl-F hydrochloride (dl-F) t.i.d. and capsules of 15 mg d-F hydrochloride (d-F) b.i.d. for 15 days.
Repeated doses of d-F plus l-F gave the same values for the parameters measured as did d-F administered alone. Steady-state concentrations of all compounds were achieved within 4–8 days. The predicted mean steady-state concentrations of d-F and elimination half-lives calculated from the results of a previous single dose study were similar to those measured at steady state in this study, confirming the lack of effect of the drug on hepatic microsomal enzymes and on kinetics after repeated dosing. d-NF concentrations were approximately half those of the parent drug and the half-life was almost twice as long. Steady state concentrations both of L-f and l-NF were consistently about 40–50% higher than of the d-isomers and there was a comparable in the half-life.
Similar content being viewed by others
References
Beckett AH, Brookes LG (1967) The absorption and urinary excretion in man of fenfluramine and its main metabolite. J Pharm Pharmacol 19: 42S-49S
Campbell DB (1971) Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration. Br J Pharmacol 43: 465P-466P
Beckett AH, Salmon JA (1972) Pharmacokinetics of absorption, distribution and elimination of fenfluramine and its main metabolite in man. J Pharma Pharmacol 24: 108–114
Belvedere G, Tognoni G, Morselli PL (1972) A new sensitive gas-chromatographic method for the determination of fenfluramine in biological specimens. Eur J Clin Pharmacol 5: 62–64
Bruce RB, Maynard WR Jr (1968) Fenfluramine metabolism. J Pharm Sci 57: 1173–1176
Beckett AH, Brookes LG (1970) The effect of chain and ring substitution on the metabolism distribution and biological action of amphetamines. In: Costa E, Garattini S (eds) Amphetamines and related compounds. Raven Press, New York, pp 109–120
Beckett AH, Coutts RT, Ogunbona FA (1973) N-ethyl-α-methyl-α-(m-trifluoromethylbenzyl)nitrone. The major in vitro metabolic product of fenfluramine in guinea-pig liver microsomal fractions. J Pharm Pharmacol 25: 190–192
Sherman AD, Gal EM (1977) Cerebral metabolism of intraventricular [3H]-fenfluramine. Neuropharmacology 16: 309–315
Midha KK, Hawes EM, Cooper JK, Hubbard JW, Bailey K, McGilveray IJ (1983) The identification of two new urinary metabolites of fenfluramine in man. Xenobiotica 13: 31–38
Morgan CD, Cattabeni F, Costa E (1972) Methamphetamine, fenfluramine and their N-dealkylated metabolites: Effect on monoamine concentrations in rat tissues. J Pharm Pharmacol 180: 127–135
Caccia S, Ballabio M, Guiso G, Rocchetti M, Garattini S (1982) Species differences in the kinetics and metabolism of fenfluramine isomers. Arch Int Pharmacodyn Ther 258: 15–28
Garattini S, Caccia S, Mennini T, Samanin R, Consolo S, Ladinsky H (1979) Biochemical pharmacology of the anorectic drug fenfluramine: A review. Curr Med Res Opin 6 [Suppl 1]: 15–27
Caccia S, Ballabio M, de Ponte P (1979) Pharmacokinetics of fenfluramine enantiomers in man. Eur J Drug Metabol Pharmacokinet 4: 129–132
Beregi LG, Hugon P, leDouarec JC, Laubie M, Duhault J (1970) Structure, activity relationships in CF3 substituted phenethylamines. In: Costa E, Garattini S (eds) Amphetamines and related compounds. Raven Press, New York, pp 21–61
Caccia S, Jori A (1977) Gas-liquid chromatographic determination of the optical isomers of fenfluramine and norfenfluramine in biological samples. J Chromatogr 144: 127–131
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caccia, S., Conforti, I., Duchier, J. et al. Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given d- and dl-fenfluramine for 15 days. Eur J Clin Pharmacol 29, 221–224 (1985). https://doi.org/10.1007/BF00547426
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00547426